Skip to main content
PMC home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 2003 Jan;60(1):50–55. doi: 10.1136/oem.60.1.50

Update of predictions of mortality from pleural mesothelioma in the Netherlands

O Segura 1, A Burdorf 1, C Looman 1
PMCID: PMC1740374  PMID: 12499457

Abstract

Aims: To predict the expected number of pleural mesothelioma deaths in the Netherlands from 2000 to 2028 and to study the effect of main uncertainties in the modelling technique.

Methods: Through an age-period-cohort modelling technique, age specific mortality rates and cohort relative risks by year of birth were calculated from the mortality of pleural mesothelioma in 1969–98. Numbers of death for both sexes were predicted for 2000 to 2028, taking into account the most likely demographic development. In a sensitivity analysis the relative deviation of the future death toll and peak death number were studied under different birth cohort risk assumptions.

Results: The age-cohort model on mortality 1969–98 among men showed the highest age specific death rates in the oldest age group (79 per 100 000 person-years in the age group 80–84 years) and the highest relative risks for the birth cohorts of 1938–42 and 1943–47. Among men a small period effect was observed. The age-cohort model was considered the best model for predicting future mortality. The most plausible scenario predicts an increase in pleural mesothelioma mortality up to 490 cases per year in men, with a total death toll close to 12 400 cases during 2000–28. However, using different assumptions this death toll could rise to nearly 15 000 in men (20% increase). Mortality among women remains low, with a total death toll of about 800 cases. It is predicted that the total death toll in the period 2000–28 is 44% lower than previous predictions using mortality data from 1969 to 1993.

Conclusion: Adding five recent years of observed mortality in an age-cohort model resulted in a 44% lower prediction of the future death toll of pleural mesothelioma. A statistically significant period effect was observed, possibly influenced by initial asbestos safety guidelines in the 1970s and introduction of the ICD-10 codification.

Full Text

The Full Text of this article is available as a PDF (170.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson E., Torén K. Pleural mesotheliomas are underreported as occupational cancer in Sweden. Am J Ind Med. 1995 Apr;27(4):577–580. doi: 10.1002/ajim.4700270411. [DOI] [PubMed] [Google Scholar]
  2. Boffetta P., Burdorf A., Goldberg M., Merler E., Siemiatycki J. Towards the coordination of European research on the carcinogenic effects of asbestos. Scand J Work Environ Health. 1998 Aug;24(4):312–317. [PubMed] [Google Scholar]
  3. Boffetta P. Health effects of asbestos exposure in humans: a quantitative assessment. Med Lav. 1998 Nov-Dec;89(6):471–480. [PubMed] [Google Scholar]
  4. Bullard J., Coleman M. P., Robinson D., Lutz J. M., Bell J., Peto J. Completeness of cancer registration: a new method for routine use. Br J Cancer. 2000 Mar;82(5):1111–1116. doi: 10.1054/bjoc.1999.1048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burdorf A., Swuste P. An expert system for the evaluation of historical asbestos exposure as diagnostic criterion in asbestos-related diseases. Ann Occup Hyg. 1999 Jan;43(1):57–66. [PubMed] [Google Scholar]
  6. Burdorf L., Swuste P. H., Heederik D. A history of awareness of asbestos disease and the control of occupational asbestos exposures in The Netherlands. Am J Ind Med. 1991;20(4):547–555. doi: 10.1002/ajim.4700200409. [DOI] [PubMed] [Google Scholar]
  7. Clayton D., Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med. 1987 Jun;6(4):469–481. doi: 10.1002/sim.4780060406. [DOI] [PubMed] [Google Scholar]
  8. Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999 Aug;56(8):505–513. doi: 10.1136/oem.56.8.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holford T. R. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health. 1991;12:425–457. doi: 10.1146/annurev.pu.12.050191.002233. [DOI] [PubMed] [Google Scholar]
  10. Ilg A. G., Bignon J., Valleron A. J. Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med. 1998 Nov;55(11):760–765. doi: 10.1136/oem.55.11.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Järvholm B., Englund A., Albin M. Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med. 1999 Feb;56(2):110–113. doi: 10.1136/oem.56.2.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kjaergaard J., Andersson M. Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scand J Work Environ Health. 2000 Apr;26(2):112–117. doi: 10.5271/sjweh.520. [DOI] [PubMed] [Google Scholar]
  13. Kupper L. L., Janis J. M., Karmous A., Greenberg B. G. Statistical age-period-cohort analysis: a review and critique. J Chronic Dis. 1985;38(10):811–830. doi: 10.1016/0021-9681(85)90105-5. [DOI] [PubMed] [Google Scholar]
  14. La Vecchia C., Decarli A., Peto J., Levi F., Tomei F., Negri E. An age, period and cohort analysis of pleural cancer mortality in Europe. Eur J Cancer Prev. 2000 Jun;9(3):179–184. [PubMed] [Google Scholar]
  15. Lee W. C., Lin R. S. Analysis of cancer rates using excess risk age-period-cohort models. Int J Epidemiol. 1995 Aug;24(4):671–677. doi: 10.1093/ije/24.4.671. [DOI] [PubMed] [Google Scholar]
  16. Mossman B. T., Gee J. B. Asbestos-related diseases. N Engl J Med. 1989 Jun 29;320(26):1721–1730. doi: 10.1056/NEJM198906293202604. [DOI] [PubMed] [Google Scholar]
  17. Peto J., Decarli A., La Vecchia C., Levi F., Negri E. The European mesothelioma epidemic. Br J Cancer. 1999 Feb;79(3-4):666–672. doi: 10.1038/sj.bjc.6690105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Peto J., Hodgson J. T., Matthews F. E., Jones J. R. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995 Mar 4;345(8949):535–539. doi: 10.1016/s0140-6736(95)90462-x. [DOI] [PubMed] [Google Scholar]
  19. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 1997 Feb 1;145(3):211–218. doi: 10.1093/oxfordjournals.aje.a009093. [DOI] [PubMed] [Google Scholar]
  20. Robertson C., Boyle P. Age-period-cohort analysis of chronic disease rates. I: Modelling approach. Stat Med. 1998 Jun 30;17(12):1305–1323. doi: 10.1002/(sici)1097-0258(19980630)17:12<1305::aid-sim853>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  21. Sterman D. H., Kaiser L. R., Albelda S. M. Advances in the treatment of malignant pleural mesothelioma. Chest. 1999 Aug;116(2):504–520. doi: 10.1378/chest.116.2.504. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES